Logo Logo
Hilfe
Hilfe
Switch Language to English

Schulte-Baukloh, Heinrich; Bauer, Ricarda; Jost, Wolfgang; Wissel, Jörg und van Ophoven, Arndt (2019): Botulinumtoxin bei Blasenfunktionsstörungen. In: Fortschritte der Neurologie Psychiatrie, Bd. 87, Nr. 1: S. 23-30

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

An overactive neurogenic detrusor and an non-neurogenic overactive bladder both exhibit symptoms such as urgency and frequency, both with and without urinary incontinence, and are often accompanied by nocturia. OnabotulinumtoxinA-Detrusorinjection has become well established as a second line therapy in cases where anticholinergic medication has failed. The procedure can be performed under general or local anesthesia, in both in- and outpatient settings. The side effects of the procedure are primarily urinary tract infections and - especially in neurogenic bladder patients - urinary retention. This article focuses on the approved indications and summarizes the current scientific data.

Dokument bearbeiten Dokument bearbeiten